Abstracts

Antiretroviral Therapy Is Associated With Significant Changes in Plasma Lipidome

Background: Targeted measurement of over 400 plasma lipid species by mass spectrometry can sensitively identify changes in the plasma lipidome associated with the development of atherosclerosis and stratify patients into levels of future cardiovascular risk. Some of the HIV and ART-associated cardiovascular risk that persists despite correction for fasting lipids may be explained by changes…

Lipidomic Profiling in HIV: Implications for Risk-Prediction Models

Background: HIV positive patients are at increased risk for coronary artery disease (CAD) with both HIV and antiretroviral associated dyslipidaemia contributing. Targeted analysis of over 400 plasma lipid species by mass spectrometry can sensitively identify changes in the plasma lipidome associated with the development of atherosclerosis. Methodology: In a retrospective case-control study we profiled the…

Abacavir induces leukocyte accumulation through the interaction of ATP and P2X receptors

Background: The use of abacavir has been linked to cardiovascular disease. We have demonstrated (using a flow chamber system in vitro) that cyclic purine analogues (abacavir and didanosine) induce leukocyte-endothelial cell interactions through Mac-1/ICAM-1 interaction, and that this effect is not produced by pyrimidine analogues (lamivudine, zidovudine, emtricitabine) or the acyclic nucleotide tenofovir. However, the…

Darunavir or Atazanavir vs Raltegravir Lipid Changes Are Unlinked to Ritonavir Exposure: ACTG 5257

Background: Lipid profiles following antiretroviral therapy (ART) vary by regimen type and by ritonavir (RTV) exposure. Changes in fasting lipid profile (FLP) were assessed after ART initiation and correlated with plasma RTV trough concentrations (C24) in the A5257 study. Methodology: ART-naive individuals >age 18 years with HIV-1 RNA level>1000 copies/mL were eligible. Subjects were randomized…

LDL particles and lipoprotein-phospholipase A2 in naive HIV+ patients randomized to DRV/r vs ATV/r

Background: Atadar study compared plasma lipids in HIV naive patients randomized to Atazanavir/ritonavir (ATV/r) or darunavir/ritonavir (DRV/r) plus tenofovir/emtricitabine (NCT 01274780, 11th HIV Congress, Glasgow 2012, abstract O423). The aim of this substudy was to obtain a more profound knowledge of the proinflammatory properties of lipid changes by the analysis of LDL particles and lipoprotein-phospholipase…

Rosuvastatin Lowers Cystatin C in HIV-Infected Subjects on Antioretroviral Therapy: SATURN-HIV

Background: In chronic HIV-infection, both creatinine and cystatin C (CysC) based estimates of glomerular filtration rate (eGFRcr and eGFRcys) are less accurate than combined estimates (eGFRcr-cys) when compared to measured GFR; however, eGFRcys is a better predictor of mortality. This may be explained by non-GFR determinants of plasma cystatin C levels, particularly inflammation. Statins may…

Is There Continued Evidence for an Association Between Abacavir and Myocardial Infarction Risk?

Background: In March 2008, the D:A:D study published results showing an increased risk of myocardial infarction (MI) in those on abacavir (ABC). We describe changes in use of ABC since publication, and reinvestigate this association with subsequent follow-up. Methodology: D:A:D participants were followed from study entry until the first of: MI, death, 1st Feb 2013…

Effect of Switch From Abacavir to Tenofovir DF on Platelet Function Markers: A SWIFT Trial Substudy

Background: Current and recent use of the nucleoside reverse transcriptase inhibitor, abacavir (ABC) has been associated with increased risk of myocardial infarction, with both endothelial dysfunction and altered platelet reactivity with ABC use implicated. Methodology: Changes in markers of platelet function were examined in a sub-study of the SWIFT trial, a prospective, randomised, 48-week trial…

Suicide Rates Decrease Among HAART Initiators from 1996 to 2012 in British Columbia Canada

Background: Suicide rates among people living with HIV/AIDS (PLHIV) have been reported at markedly higher levels than in the general population. We sought to evaluate this trend and identify factors associated with suicide among PLHIV who have initiated Highly Active Antiretroviral Therapy (HAART) in British Columbia (BC), Canada. Methodology: Our analysis was based on all…